Answers are grounded in this paper and cite their sources.
Fifteen 13-ester, 13-carbanilate and 15-hydroxy derivatives of virginiamycin M1 were synthesized and evaluated for their abilities to inhibit a) binding to the cholecystokinin receptor subtypes in guinea-pig brain (CCK-B) and rat pancreas (CCK-A), and b) microbial growth.
No takes yet. Share an insight, caveat, or question.
LAM et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: